Late-night and low-dose dexamethasone-suppressed cortisol in saliva and serum for the diagnosis of cortisol-secreting adrenal adenomas

European Journal of Endocrinology

Volumn 161, Issue 5, 2009, Pages 747-753

  Deutschbein, Timo ^a   Unger, Nicole ^a   Hinrichs, Jakob ^b   Walz, Martin K ^b   Mann, Klaus ^a   Petersenn, Stephan ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b KLINIKEN ESSEN MITTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; DEXAMETHASONE; HYDROCORTISONE; DIAGNOSTIC AGENT;

ADRENAL CORTEX ADENOMA; ADULT; ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SALIVA LEVEL; SCREENING; SENSITIVITY AND SPECIFICITY; ADENOMA; ADRENAL TUMOR; BLOOD; COMPARATIVE STUDY; CUSHING SYNDROME; DOSE RESPONSE; DRUG EFFECT; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; ROC CURVE; SALIVA; SECRETION;

ADENOMA; ADRENAL GLAND NEOPLASMS; ADRENOCORTICOTROPIC HORMONE; ADULT; CUSHING SYNDROME; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; ROC CURVE; SALIVA; SENSITIVITY AND SPECIFICITY;

EID: 70449722916     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0517     Document Type: Article

References (46)

1. Kloos RT, Gross MD, Francis IR, Korobkin M & Shapiro B. Incidentally discovered adrenal masses. Endocrine Reviews 1995 16 460-484.
2. Young WF Jr. Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota. Endocrinology and Metabolism Clinics of North America 2000 29 159-185.
3. Song JH, Chaudhry FS & Mayo-Smith WW. The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. American Journal of Roentgenology 2008 190 1163-1168.
4. Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Ali A, Giovagnetti M, Opocher G & Angeli A. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. Journal of Clinical Endocrinology and Metabolism 2000 85 637-644.
5. Mansmann G, Lau J, Balk E, Rothberg M, Miyachi Y & Bornstein SR. The clinically inapparent adrenal mass: update in diagnosis and management. Endocrine Reviews 2004 25 309-340. (Pubitemid 38528713)
6. Newell-Price J, Bertagna X, Grossman AB & Nieman LK. Cushing's syndrome. Lancet 2006 367 1605-1617.
7. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM & Montori VM. The diagnosis of Cushing's syndrome: an endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 2008 93 1526-1540. (Pubitemid 351656485)
8. Lewis JG. Steroid analysis in saliva: an overview. Clinical Biochemist. Reviews 2006 27 139-146.
9. Luthold WW, Marcondes JA & Wajchenberg BL. Salivary cortisol for the evaluation of Cushing's syndrome. Clinica Chimica Acta 1985 151 33-39.
10. Raff H, Raff JL & Findling JW. Late-night salivary cortisol as a screening test for Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 1998 83 2681-2686. (Pubitemid 28493760)
11. Castro M, Elias PC, Quidute AR, Halah FP & Moreira AC. Out-patient screening for Cushing's syndrome: the sensitivity of the combination of circadian rhythm and overnight dexamethasone suppression salivary cortisol tests. Journal of Clinical Endocrinology and Metabolism 1999 84 878-882. (Pubitemid 29138212)
12. Papanicolaou DA, Mullen N, Kyrou I & Nieman LK. Nighttime salivary cortisol: a useful test for the diagnosis of Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 2002 87 4515-4521. (Pubitemid 35247034)
13. Putignano P, Toja P, Dubini A, Pecori Giraldi F, Corsello SM & Cavagnini F. Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 2003 88 4153-4157. (Pubitemid 37153715)
14. Yaneva M, Mosnier-Pudar H, Dugue MA, Grabar S, Fulla Y & Bertagna X. Midnight salivary cortisol for the initial diagnosis of Cushing's syndrome of various causes. Journal of Clinical Endocrinology and Metabolism 2004 89 3345-3351. (Pubitemid 38951902)
15. Trilck M, Flitsch J, Ludecke DK, Jung R & Petersenn S. Salivary cortisol measurement - a reliable method for the diagnosis of Cushing's syndrome. Experimental and Clinical Endocrinology & Diabetes 2005 113 225-230.
16. Viardot A, Huber P, Puder JJ, Zulewski H, Keller U & Muller B. Reproducibility of nighttime salivary cortisol and its use in the diagnosis of hypercortisolism compared with urinary free cortisol and overnight dexamethasone suppression test. Journal of Clinical Endocrinology and Metabolism 2005 90 5730-5736. (Pubitemid 41415483)
17. Papanicolaou DA, Yanovski JA, Cutler GB Jr, Chrousos GP & Nieman LK. A single midnight serum cortisol measurement distinguishes Cushing's syndrome from pseudo-Cushing states. Journal of Clinical Endocrinology and Metabolism 1998 83 1163-1167.
18. Reimondo G, Allasino B, Bovio S, Paccotti P, Angeli A & Terzolo M. Evaluation of the effectiveness of midnight serum cortisol in the diagnostic procedures for Cushing's syndrome. European Journal of Endocrinology 2005 153 803-809. (Pubitemid 43020230)
19. Newell-Price J, Trainer P, Perry L,Wass J, Grossman A & Besser M. A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome. Clinical Endocrinology 1995 43 545-550.
20. Gorges R, Knappe G, Gerl H, Ventz M & Stahl F. Diagnosis of Cushing's syndrome: re-evaluation of midnight plasma cortisol vs urinary free cortisol and low-dose dexamethasone suppression test in a large patient group. Journal of Endocrinological Investigation 1999 22 241-249. (Pubitemid 29224321)
21. Meulenberg PM, Ross HA, Swinkels LM & Benraad TJ. The effect of oral contraceptives on plasma-free and salivary cortisol and cortisone. Clinica Chimica Acta 1987 165 379-385.
22. Hamrahian AH, Oseni TS & Arafah BM. Measurements of serum free cortisol in critically ill patients. New England Journal of Medicine 2004 350 1629-1638. (Pubitemid 38501164)
23. Klose M, Lange M, Rasmussen AK, Skakkebaek NE, Hilsted L, Haug E, Andersen M & Feldt-Rasmussen U. Factors influencing the adrenocorticotropin test: role of contemporary cortisol assays, body composition, and oral contraceptive agents. Journal of Clinical Endocrinology and Metabolism 2007 92 1326-1333. (Pubitemid 46556405)
24. Umeda T, Hiramatsu R, Iwaoka T, Shimada T, Miura F & Sato T. Use of saliva for monitoring unbound free cortisol levels in serum. Clinica Chimica Acta 1981 110 245-253. (Pubitemid 11102567)
25. Vining RF, McGinley RA & Symons RG. Hormones in saliva: mode of entry and consequent implications for clinical interpretation. Clinical Chemistry 1983 29 1752-1756.
26. Chen YM, Cintron NM & Whitson PA. Long-term storage of salivary cortisol samples at room temperature. Clinical Chemistry 1992 38 304.
27. Clements AD & Parker CR. The relationship between salivary cortisol concentrations in frozen versus mailed samples. Psychoneuroendocrinology 1998 23 613-616.
28. Groschl M, Wagner R, Rauh M & Dorr HG. Stability of salivary steroids: the influences of storage, food and dental care. Steroids 2001 66 737-741. (Pubitemid 32755770)
29. Kivlighan KT, Granger DA, Schwartz EB, Nelson V, Curran M & Shirtcliff EA. Quantifying blood leakage into the oral mucosa and its effects on the measurement of cortisol, dehydroepiandrosterone, and testosterone in saliva. Hormones and Behavior 2004 46 39-46. (Pubitemid 38822935)
30. Nunes ML, Vattaut S, Corcuff JB, Rault A, Loiseau H, Gatta B, Valli N, Letenneur L & Tabarin A. Late-night salivary cortisol for diagnosis of overt and subclinical Cushing's syndrome in hospitalized and ambulatory patients. Journal of Clinical Endocrinology and Metabolism 2009 79 1532-1539.
31. Huiras CM, Pehling GB & Caplan RH. Adrenal insufficiency after operative removal of apparently nonfunctioning adrenal adenomas. Journal of the American Medical Association 1989 261 894-898.
32. Osella G, Terzolo M, Borretta G, Magro G, Ali A, Piovesan A, Paccotti P & Angeli A. Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas). Journal of Clinical Endocrinology and Metabolism 1994 79 1532-1539.
33. Tsagarakis S, Roboti C, Kokkoris P, Vasiliou V, Alevizaki C & Thalassinos N. Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas. Clinical Endocrinology 1998 49 165-171. (Pubitemid 28372643)
34. Emral R, Uysal AR, Asik M, Gullu S, Corapcioglu D, Tonyukuk V & Erdogan G. Prevalence of subclinical Cushing's syndrome in 70 patients with adrenal incidentaloma: clinical, biochemical and surgical outcomes. Endocrine Journal 2003 50 399-408. (Pubitemid 37129032)
35. Grumbach MM, Biller BM, Braunstein GD, Campbell KK, Carney JA, Godley PA, Harris EL, Lee JK, Oertel YC, Posner MC, Schlechte JA & Wieand HS. Management of the clinically inapparent adrenal mass ("incidentaloma") . Annals of Internal Medicine 2003 138 424-429. (Pubitemid 36262654)
36. Cronin C, Igoe D, Duffy MJ, Cunningham SK & McKenna TJ. The overnight dexamethasone test is a worthwhile screening procedure. Clinical Endocrinology 1990 33 27-33. (Pubitemid 20197156)
37. Montwill J, Igoe D & McKenna TJ. The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome. Steroids 1994 59 296-298. (Pubitemid 24149999)
38. Wood PJ, Barth JH, Freedman DB, Perry L & Sheridan B. Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome - recommendations for a protocol for biochemistry laboratories. Annals of Clinical Biochemistry 1997 34 222-229. (Pubitemid 27236924)
39. Valli N, Catargi B, Ronci N, Vergnot V, Leccia F, Ferriere JM, Chene G, Grenier N, Laurent F & Tabarin A. Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas. European Journal of Endocrinology 2001 144 401-408. (Pubitemid 32409594)
40. Isidori AM, Kaltsas GA, Mohammed S, Morris DG, Jenkins P, Chew SL, Monson JP, Besser GM & Grossman AB. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 2003 88 5299-5306. (Pubitemid 37452731)
41. Barrou Z, Guiban D, Maroufi A, Fournier C, Dugue MA, Luton JP & Thomopoulos P. Overnight dexamethasone suppression test: comparison of plasma and salivary cortisol measurement for the screening of Cushing's syndrome. European Journal of Endocrinology 1996 134 93-96. (Pubitemid 26034355)
42. Cardoso EM, Arregger AL, Tumilasci OR & Contreras LN. Diagnostic value of salivary cortisol in Cushing's syndrome (CS). Clinical Endocrinology 2009 70 516-521.
43. Crapo L. Cushing's syndrome: a review of diagnostic tests. Metabolism 1979 28 955-977. (Pubitemid 9256926)
44. Findling JW, Raff H & Aron DC. The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 2004 89 1222-1226. (Pubitemid 38368417)
45. Terzolo M, Reimondo G, Bovio S & Angeli A. Subclinical Cushing's syndrome. Pituitary 2004 7 217-223.
46. Raff H, Homar PJ & Burns EA. Comparison of two methods for measuring salivary cortisol. Clinical Chemistry 2002 48 207-208. (Pubitemid 34038149)